BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 869060)

  • 1. Platelet monoamine oxidase in chronic schizophrenia.
    Berrettini WH; Vogel WH; Clouse R
    Am J Psychiatry; 1977 Jul; 134(7):805-7. PubMed ID: 869060
    [No Abstract]   [Full Text] [Related]  

  • 2. [The study of the platelet monoamine oxidase activity in chronic schizophrenic patients (author's transl)].
    Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
    Seishin Shinkeigaku Zasshi; 1977 Oct; 79(10):563-7. PubMed ID: 607254
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet monoamine oxidase activity in chronic schizophrenia.
    Trivedi JK; Tandon SK; Viswanathan PN; Gupta AK; Sethi BB
    Indian J Med Res; 1987 Jul; 86():79-83. PubMed ID: 3692563
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet monoamineoxidase activity in chronic schizophrenics.
    Gerbaldo H; Rozados RV; Filinger EJ
    Medicina (B Aires); 1985; 45(1):22-4. PubMed ID: 3880103
    [No Abstract]   [Full Text] [Related]  

  • 5. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.
    Wyatt RJ; Murphy DL; Belmaker R; Cohen S; Donnelly CH; Pollin W
    Science; 1973 Mar; 179(4076):916-8. PubMed ID: 4687789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase activity in schizophrenia.
    White HL; McLeod MN; Davidson JR
    Am J Psychiatry; 1976 Oct; 133(10):1191-3. PubMed ID: 970490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls.
    Nies A; Robinson DS; Harris LS; Lamborn KR
    Adv Biochem Psychopharmacol; 1974; 12(0):59-70. PubMed ID: 4607593
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet monoamine oxidase activity in schizophrenia: a review of the data.
    Wyatt RJ; Potkin SG; Murphy DL
    Am J Psychiatry; 1979 Apr; 136(4A):377-85. PubMed ID: 371419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY; Stahl SM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet monoamine oxidase activity in patients with chronic schizophrenic illnesses untreated by neuroleptic drugs [proceedings].
    Bailey AR; Crow TJ; Johnstone EC; Owen F
    Br J Clin Pharmacol; 1975 Aug; 2(4):380P. PubMed ID: 1234010
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An endogenous inhibitor of platelet MAO activity in chronic schizophrenia: failure to replicate.
    Wise CD; Potkin S; Bridge P; Wyatt RJ
    Am J Psychiatry; 1979 Oct; 136(10):1336-7. PubMed ID: 484736
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary study on platelet monoamine oxidase in schizophrenic patients].
    Huang MS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):193-6. PubMed ID: 7261730
    [No Abstract]   [Full Text] [Related]  

  • 15. [A long-term observation of the platelet monoamine oxidase activity in schizophrenic patients (author's transl)].
    Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
    Seishin Shinkeigaku Zasshi; 1978 Mar; 80(3):121-4. PubMed ID: 662975
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG; Becker RE
    Psychopharmacol Bull; 1975 Jul; 11(3):39-40. PubMed ID: 1153659
    [No Abstract]   [Full Text] [Related]  

  • 17. Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients.
    Freed WJ; Kleinman JE; Karson CN; Potkin SG; Murphy DL; Wyatt RJ
    Biol Psychiatry; 1980 Apr; 15(2):329-32. PubMed ID: 7417620
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates.
    Baron M; Perumal AS; Levitt M; Cannova G
    Biol Psychiatry; 1982 Apr; 17(4):479-83. PubMed ID: 7082713
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet MAO activity and schizophrenic prognosis.
    Gruen R; Baron M; Levitt M; Asnis L
    Am J Psychiatry; 1982 Feb; 139(2):240-1. PubMed ID: 7055302
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of oral glucose on platelet monoamine oxidase.
    Karson CN; Bridge TP; Phelps BH; Wise CD; Potkin SG; Apostoles PS; Wyatt RJ
    Biol Psychiatry; 1982 Sep; 17(9):1011-5. PubMed ID: 7138991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.